Client News
Filter by:
- Mar 4 2024 Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
- Mar 4 2024 Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort
- Mar 1 2024 ASHFORD ANNOUNCES ACCEPTANCE OF COMPLIANCE PLAN BY NYSE AMERICAN
- Feb 29 2024 Kineta Announces Restructuring and Exploration of Strategic Alternatives
- Feb 29 2024 ASHFORD HOSPITALITY TRUST ANNOUNCES PROGRESS IN PLAN TO PAY OFF STRATEGIC FINANCING WITH AGREEMENT TO SELL THE HILTON BOSTON BACK BAY
- Feb 28 2024 Cemtrex Issues Shareholder Letter and Provides Corporate Update
- Feb 28 2024 Zevra Therapeutics to Participate at Upcoming Investor Conferences
- Feb 26 2024 Iveda Awarded $3.2M Contract for Confidential Application by Taiwanese Government Agency
- Feb 26 2024 ASHFORD HOSPITALITY TRUST PROVIDES UPDATE ON PLAN TO PAY OFF STRATEGIC FINANCING
- Feb 26 2024 Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results